Eiad Habib, Jay Patel, Connor Kerndt, Dan Summers and TaLawnda Bragg. A Rare Case of Anti-NMDA Receptor Encephalitis Associated with an Ovarian Teratoma.
. 2021; 9(7):354-357. doi: 10.12691/AJMCR-9-7-3
paraneoplastic, anti-NMDA, receptor, encephalitis, ovarian teratoma
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
[1] | K. Nokura, H. Yamamoto, Y. Okawara, H. Koga, H. Osawa, and K. Sakai, “Reversible limbic encephalitis caused by ovarian teratoma,” Acta Neurol. Scand., vol. 95, no. 6, pp. 367-373, 1997. |
|
[2] | H. Okamura, N. Oomori, and Y. Uchitomi, “An acutely confused 15-year-old girl,” Lancet, vol. 350, no. 9076, p. 488, Aug. 1997. |
|
[3] | R. Vitaliani, W. Mason, B. Ances, T. Zwerdling, Z. Jiang, and J. Dalmau, “Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma,” Ann. Neurol., vol. 58, no. 4, pp. 594-604, 2005. |
|
[4] | J. Dalmau et al., “Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies,” Lancet Neurol., vol. 7, no. 12, pp. 1091-1098, Dec. 2008. |
|
[5] | A. P. Mann, E. Grebenciucova, and R. V. Lukas, “Anti-N-methyl-D-aspartate-receptor encephalitis: Diagnosis, optimal management, and challenges,” Therapeutics and Clinical Risk Management, vol. 10, no. 1. Dove Medical Press Ltd., pp. 517-524, 2014. |
|
[6] | J. A. Braverman, C. Marcus, and R. Garg, “Anti-NMDA-receptor encephalitis: A neuropsychiatric syndrome associated with ovarian teratoma,” Gynecol. Oncol. Reports, vol. 14, pp. 1-3, Nov. 2015. |
|
[7] | M. J. Titulaer et al., “Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study,” Lancet Neurol., vol. 12, no. 2, pp. 157-165, Feb. 2013. |
|
[8] | J. Dalmau et al., “Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma,” Ann. Neurol., vol. 61, no. 1, pp. 25-36, Jan. 2007. |
|
[9] | J. Dalmau, E. Lancaster, E. Martinez-Hernandez, M. R. Rosenfeld, and R. Balice-Gordon, “Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis,” The Lancet Neurology, vol. 10, no. 1. Lancet Neurol, pp. 63-74, Jan-2011. |
|
[10] | H. C. Chiu, Y. C. Su, S. C. Huang, H. L. Chiang, and P. S. Huang, “Anti-NMDAR encephalitis with ovarian teratomas: Review of the literature and two case reports,” Taiwan. J. Obstet. Gynecol., vol. 58, no. 3, pp. 313-317, May 2019. |
|
[11] | M. S. Kayser and J. Dalmau, “Anti-NMDA Receptor Encephalitis in Psychiatry,” Curr. Psychiatry Rev., vol. 7, no. 3, pp. 189-193, Aug. 2011. |
|
[12] | P. Acién, M. Acién, E. Ruiz-Maciá, and C. Martín-Estefanía, “Ovarian teratoma-associated anti-NMDAR encephalitis: a systematic review of reported cases,” Orphanet J. Rare Dis., vol. 9, no. 1, p. 157, Dec. 2014. |
|
[13] | M. G. Ferreira, V. L. Alcalde, M. H. G. Sánchez, L. H. Hernández, and M. J. Doyague Sánchez, “Successful treatment of anti-NMDA receptor encephalitis with early teratoma removal and plasmapheresis: A case report,” Med. (United States), vol. 97, no. 31, Aug. 2018. |
|
[14] | A. D. Mitra and A. Afifya, “Ovarian teratoma associated Anti N-methyl-D-aspartate receptor encephalitis: A difficult diagnosis with a favorable p¬rognosis.,” Autops. Case Reports, vol. 8, no. 2, 2018. |
|
[15] | A. Tumbi, A. Gilani, J. R. Scarff, G. Kaur, and S. Lippmann, “Anti-N-methyl-D encephalitis.,” Innov. Clin. Neurosci., vol. 8, no. 9, pp. 24-5, 2011. |
|